Gilead Sciences Inc (GILD) stock saw a modest uptick, ending the day at $92.37 which represents a slight increase of $0.36 or 0.39% from the prior close of $92.01. The stock opened at $92.59 and ...

Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) was the target of a large drop in short interest in the month of December. As of December 15th, there was short interest totalling 21,980,000 ...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD ...

The boards of directors (each a "Board") of HOOKIPA Pharma Inc. ("HOOKIPA") and Poolbeg Pharma plc ("Poolbeg") are pleased to announce that they have entered into non-binding discussions for an ...

Under the proposed terms, shareholders in the London-based clinical stage biopharmaceutical firm would receive 0.03 Hookipa shares for each Poolbeg share. This would leave Poolbeg with 55% of the ...

HOOKIPA Pharma Inc. (HOOK) has experienced a significant surge in its stock price, up +19.90% to $2.41 in Thursday’s premarket trading session, following an exciting announcement about a potential ...

Horsley continued to celebrate the history he made decades ago while anchoring communities like Mount Gilead Missionary ...

New Delhi, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The global gene therapy market was valued at US$ 9.42 billion in 2024 and is projected to hit the market valuation of US$ 42.26 billion by 2033 at a CAGR ...

Senior Officer Vesta Filipchuk sold 40,000 shares of NorthWest Copper stock in a transaction on Monday, December 30th. The shares were sold at an average price of C$0.29, for a total transaction of ...